These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 24751385

  • 1. Survival of motor neuron protein downregulates miR-9 expression in patients with spinal muscular atrophy.
    Wang LT, Chiou SS, Liao YM, Jong YJ, Hsu SH.
    Kaohsiung J Med Sci; 2014 May; 30(5):229-34. PubMed ID: 24751385
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy.
    Wen HL, Ting CH, Liu HC, Li H, Lin-Chao S.
    Neurobiol Dis; 2013 Apr; 52():94-103. PubMed ID: 23268200
    [Abstract] [Full Text] [Related]

  • 4. Therapeutics development for spinal muscular atrophy.
    Sumner CJ.
    NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.
    Grzeschik SM, Ganta M, Prior TW, Heavlin WD, Wang CH.
    Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920
    [Abstract] [Full Text] [Related]

  • 8. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
    See K, Yadav P, Giegerich M, Cheong PS, Graf M, Vyas H, Lee SG, Mathavan S, Fischer U, Sendtner M, Winkler C.
    Hum Mol Genet; 2014 Apr 01; 23(7):1754-70. PubMed ID: 24218366
    [Abstract] [Full Text] [Related]

  • 9. Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy.
    Sison SL, Patitucci TN, Seminary ER, Villalon E, Lorson CL, Ebert AD.
    Hum Mol Genet; 2017 Sep 01; 26(17):3409-3420. PubMed ID: 28637335
    [Abstract] [Full Text] [Related]

  • 10. Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) regulates the level of SMN expression through ubiquitination in primary spinal muscular atrophy fibroblasts.
    Hsu SH, Lai MC, Er TK, Yang SN, Hung CH, Tsai HH, Lin YC, Chang JG, Lo YC, Jong YJ.
    Clin Chim Acta; 2010 Dec 14; 411(23-24):1920-8. PubMed ID: 20713032
    [Abstract] [Full Text] [Related]

  • 11. A Perturbed MicroRNA Expression Pattern Characterizes Embryonic Neural Stem Cells Derived from a Severe Mouse Model of Spinal Muscular Atrophy (SMA).
    Luchetti A, Ciafrè SA, Murdocca M, Malgieri A, Masotti A, Sanchez M, Farace MG, Novelli G, Sangiuolo F.
    Int J Mol Sci; 2015 Aug 06; 16(8):18312-27. PubMed ID: 26258776
    [Abstract] [Full Text] [Related]

  • 12. In vitro gene manipulation of spinal muscular atrophy fibroblast cell line using gene-targeting fragment for restoration of SMN protein expression.
    Rashnonejad A, Gündüz C, Süslüer SY, Onay H, Durmaz B, Bandehpour M, Özkınay F.
    Gene Ther; 2016 Jan 06; 23(1):10-7. PubMed ID: 26331341
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J, Butchbach ME, Palomo M, Pease B, Rao M, Bedell L, Keyvan M, Pai G, Mishra R, Haraldsson M, Andresson T, Bragason G, Thosteinsdottir M, Bjornsson JM, Coovert DD, Burghes AH, Gurney ME, Singh J.
    J Med Chem; 2008 Feb 14; 51(3):449-69. PubMed ID: 18205293
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin-induced cell death.
    Wang W, Dimatteo D, Funanage VL, Scavina M.
    Mol Genet Metab; 2005 May 14; 85(1):38-45. PubMed ID: 15862279
    [Abstract] [Full Text] [Related]

  • 18. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
    Cobb MS, Rose FF, Rindt H, Glascock JJ, Shababi M, Miller MR, Osman EY, Yen PF, Garcia ML, Martin BR, Wetz MJ, Mazzasette C, Feng Z, Ko CP, Lorson CL.
    Hum Mol Genet; 2013 May 01; 22(9):1843-55. PubMed ID: 23390132
    [Abstract] [Full Text] [Related]

  • 19. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.
    Wolstencroft EC, Mattis V, Bajer AA, Young PJ, Lorson CL.
    Hum Mol Genet; 2005 May 01; 14(9):1199-210. PubMed ID: 15790598
    [Abstract] [Full Text] [Related]

  • 20. Co-regulation of survival of motor neuron and Bcl-xL expression: implications for neuroprotection in spinal muscular atrophy.
    Anderton RS, Price LL, Turner BJ, Meloni BP, Mitrpant C, Mastaglia FL, Goh C, Wilton SD, Boulos S.
    Neuroscience; 2012 Sep 18; 220():228-36. PubMed ID: 22732506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.